Laurel Wealth Advisors, Inc. Pacific Biosciences Of California, Inc. Transaction History

Laurel Wealth Advisors, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$4.02 - $10.43 $101,476 - $263,284	-25,243 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$19.26 - $30.08 $1,155 - $1,804	-60 Reduced 0.24%	25,243 $516,000
Q2 2021 Aug 16, 2021	BUY	$22.3 - $36.02 $3,924 - $6,339	176 Added 0.7%	25,303 $885,000
Q1 2021 May 14, 2021	BUY	$26.38 - $51.15 $3,350 - $6,496	127 Added 0.51%	25,127 $837,000
Q4 2020 Mar 03, 2021	SELL	$10.5 - $28.5 $2,100 - $5,700	-200 Reduced 0.79%	25,000 $649,000
Q3 2020 Nov 13, 2020	BUY	$3.61 - $9.87 $90,972 - $248,723	25,200 New	25,200 $249,000
Q2 2019 Aug 13, 2019	SELL	$5.92 - $7.41 $153,920 - $192,660	-26,000 Closed	0 $0
Q1 2019 May 16, 2019	BUY	$6.8 - $7.4 $176,800 - $192,400	26,000 New	26,000 $188,000

254

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $438M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Laurel Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Laurel Wealth Advisors, Inc. with notifications on news.